Acute Ischemic Stroke Diagnosis Market Research, 2033
The global acute ischemic stroke diagnosis market size was valued at $2.1 billion in 2023, and is projected to reach $3.6 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033. The rising prevalence of strokes globally, growing awareness about the importance of early diagnosis and treatment, advancements in imaging technologies such as CT and MRI for accurate diagnosis, and increasing healthcare expenditure in developing regions improving access to diagnostic facilities are the major factors which drives the market growth.
Market Introduction and Definition
Acute ischemic stroke (AIS) is a medical emergency characterized by the sudden onset of neurological dysfunction due to an obstruction of blood flow to the brain. This blockage, often caused by a thrombus or embolus, leads to brain tissue ischemia and infarction. Symptoms typically include sudden weakness or numbness on one side of the body, difficulty speaking or understanding speech, vision problems, dizziness, and severe headaches. Prompt diagnosis, primarily through clinical assessment and neuroimaging such as CT or MRI, is critical for initiating timely treatment to restore blood flow and minimize brain damage.
Key Takeaways
The acute ischemic stroke diagnosis market share study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period.
More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major acute ischemic stroke diagnosis industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and assist stakeholders in making educated decisions to achieve their most ambitious growth objectives.
Key Market Dynamics
The driving factors for the acute ischemic stroke diagnosis market growth include advancements in medical imaging technologies, such as computed tomography (CT) and magnetic resonance imaging (MRI) , which have significantly improved the accuracy and speed of diagnosing acute ischemic stroke. In addition, the rising incidence of ischemic stroke globally, driven by rise in aging population and increasing prevalence of risk factors such as hypertension, diabetes, and obesity, fuels the demand for reliable and timely diagnostic solutions. Moreover, initiatives aimed at raising awareness about the importance of early stroke detection among healthcare professionals and patients contribute to market growth. The integration of artificial intelligence (AI) and machine learning algorithms into diagnostic tools further enhances precision and efficiency in identifying stroke symptoms, facilitating prompt intervention, and improving patient outcomes. These factors collectively drive the expansion during the acute ischemic stroke diagnosis market forecast period.
However, the high cost associated with advanced diagnostic technologies, such as MRI and CT scans, limit accessibility, especially in regions with constrained healthcare budgets or infrastructure, which restrict market growth. In addition, the requirement for specialized expertise to interpret diagnostic results accurately poses another challenge, particularly in areas with a shortage of trained neurologists and radiologists further hinders market growth. Moreover, the technological advancements, such as the development of advanced imaging techniques such as CT and MRI scans, enhance the accuracy and speed of stroke diagnosis, crucial for timely intervention and improved patient outcomes which provide acute ischemic stroke diagnosis market opportunity.
Prevalence Statistics for Ischemic Stroke
According to the World Stroke Organization, the prevalence of ischemic stroke (AIS) in 2022 illustrates a notable gender disparity, with an estimated 3.4 million cases among men and 4.2 million among women globally. This data emphasizes the substantial global burden of AIS, emphasizing the urgent need for effective diagnostic and treatment strategies. In response to these prevalence rates, the acute ischemic stroke diagnosis market is increasingly driven by innovations in diagnostic technologies such as advanced imaging modalities (e.g., CT, MRI) and rapid point-of-care testing. These advancements aim to enhance early detection and facilitate prompt intervention, critical factors in mitigating the severe consequences of stroke. As healthcare systems worldwide prioritize stroke prevention and management, the market continues to evolve with a focus on improving patient outcomes through timely and accurate diagnosis across diverse demographic and geographic settings.
Market Segmentation
The acute ischemic stroke diagnosis market is segmented into technology, end user, and region. On the basis of the technology, the market is segmented into computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others. By end user, the market is divided into hospitals and clinics, ambulatory surgery centers, diagnostic laboratories and imaging centers, and others. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Regional/Country Market Outlook
Developed region such as North America lead in acute ischemic stroke diagnosis market share owing to high awareness about early diagnosis & treatment, and early adoption of advanced imaging technologies such as CT and MRI. These regions also benefit from government initiatives and extensive research and development activities, driving innovation in stroke diagnosis tools.
One such initiative is the Action Plan for Stroke in Europe 2018-2030 (European Stroke Action Plan (ESAP)) , which was developed by the European Stroke Organization (ESO) in cooperation with the Stroke Alliance for Europe (SAFE) . The ESAP included seven domains, including primary prevention, organization of stroke services, acute treatment, rehabilitation, evaluation, research, and advocacy. These initiatives aim to reduce the prevalence of strokes in Europe by improving prevention, treatment, and management strategies which contribute toward market growth.?
An article published by Centers Disease Control and Prevention (CDC) in 2024, reported that every year, more than 795, 000 people in the U.S. have a stroke.? This rise in prevalence drives the critical need for effective and efficient diagnostic tools and technologies which further support market growth.
In contrast, emerging markets in Asia-Pacific and LAMEA are witnessing rapid market growth owing to improving healthcare infrastructure, increasing healthcare expenditure, and rising stroke incidence rates associated with lifestyle changes. Further, rise in government initiatives aimed at enhancing stroke awareness and improving access to healthcare services further contribute to market expansion in these regions.
According to the Australian Institute of Health and Welfare, in 2019–20 estimated health system expenditure on stroke was more than $890 million. The greatest cost was for public hospital admitted patient services ($590.4 million) followed by private hospital services ($114.0 million) . This funding supports the adoption of advanced diagnostic technologies which drives the market growth.
Industry Trends
According to Centers for Disease Control and Prevention (CDC) , the purpose of World Stroke Day 2022, commemorated every year on 29 October, is to increase awareness and drive actions on stroke worldwide. In addition, this day provides opportunities to advocate for actions by decision makers to improve prevention of stroke, increase access to emergency medical care and provide support for survivors and caregivers. This increased advocacy and public education efforts foster a greater demand for advanced diagnostic technologies which supports the acute ischemic stroke diagnosis market size.
An article published by Centers for Disease Control and Prevention (CDC's) in May 2024, Heart Disease and Stroke Prevention (DHDSP) provides resources to all 50 states to address heart disease and stroke, including initiatives such as the WISEWOMAN program, which screens women aged 35 to 64 for chronic disease risk factors, and the Paul Coverdell National Acute Stroke Program, which aims to improve the quality of care for stroke patients. Thus, the CDC's proactive initiatives contribute significantly to market growth.
Competitive Landscape
The major players operating in the acute ischemic stroke diagnosis market include Koninklijke Philips N.V., GE Healthcare, Canon Inc., Simens, Terumo Corporation, Stryker, Fujifilm Holdings Corporation, Samsung Electronics Co. Ltd, F. Hoffmann-La Roche AG, and Boehringer Ingelheim.
Recent Key Strategies and Developments in Acute Ischemic Stroke Diagnosis Industry
In October 2023, Koninklijke Philips N.V., a global leader in health technology, and the World Stroke Organization (WSO) , the world’s only global non-governmental organization focused on stroke announced the signing of a two-year partnership aimed at improving access to high-quality stroke care.
In May 2023, Siemens Healthineers and CommonSpirit Health agreed to acquire Block Imaging. This new acquisition will provide more sustainable options and support increasing demand from U.S. hospitals, health systems, and other care sites for multi-vendor imaging parts and services.
Key Sources Referred
- National Center for Biotechnology and Information (NCBI)
- Centers for Medicare & Medicaid Services (CMS)
- National Health Service (NHS)
- Australian Government Department of Health and Aged Care
- Government of Canada's Health and Wellness
- Ministry of Health and Family Welfare (MoHFW)
- National Health Mission (NHM)
- Ayushman Bharat - Health and Wellness Centres (AB-HWCs)
- Centers for Disease Control and Prevention (CDC)
- Food and Drug Administration (FDA)
- National Institutes of Health (NIH)
- World Health Organization (WHO)
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the acute ischemic stroke diagnosis market analysis from 2024 to 2033 to identify the prevailing acute ischemic stroke diagnosis market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the acute ischemic stroke diagnosis market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global acute ischemic stroke diagnosis market trends, key players, market segments, application areas, and market growth strategies.
Acute Ischemic Stroke Diagnosis Market Report Highlights
Aspects | Details |
Market Size By 2033 | USD 3.6 Billion |
Growth Rate | CAGR of 5.7% |
Forecast period | 2024 - 2033 |
Report Pages | 228 |
By Technology |
|
By End User |
|
By Region |
|
Key Market Players | Boehringer Ingelheim International GmbH, Terumo Corporation, Simens, Samsung Electronics Co. Ltd, Stryker , GE Healthcare, Koninklijke Philips N.V., Canon Inc., Fujifilm Holdings Corporation, F. Hoffmann-La Roche Ltd |
The total market value of acute ischemic stroke diagnosis market is $2.1 billion in 2023.
The market value of acute ischemic stroke diagnosis market in 2033 is $3.6 billion.
The forecast period for acute ischemic stroke diagnosis market is 2024 to 2033.
North America dominated the market share in 2023. This is attributed to advanced healthcare infrastructure, high prevalence of strokes, widespread adoption of advanced imaging technologies, and significant investments in research and development.
The leading application of the acute ischemic stroke diagnosis market is neuroimaging, particularly using techniques such as computed tomography (CT) and magnetic resonance imaging (MRI).
The upcoming trends in the acute ischemic stroke diagnosis market include the integration of artificial intelligence (AI) for faster and more accurate image analysis, the development of portable and point-of-care diagnostic devices, and advancements in biomarkers for early detection.
Driving factors for the acute ischemic stroke diagnosis market include the increasing prevalence of strokes globally, rising awareness about the importance of early diagnosis and treatment to reduce disability and mortality rates, and advancements in medical imaging technologies such as CT and MRI for precise diagnosis.
Acute ischemic stroke diagnosis refers to the process of identifying and confirming the presence of an ischemic stroke shortly after its onset.
Loading Table Of Content...